References
- Fan X, Wang J, Song M, et al. Vitamin D status and risk of all-cause and cause-specific mortality in a large cohort: results from the UK Biobank. J Clin Endocrinol Metab 2020;105:e3606.
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
- Lee HY, Lim S, Park S. Role of inflammation in arterial calcification. Korean Circ J 2021;51:114-25.
- Chauss D, Freiwald T, McGregor R, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat Immunol 2022;23:62-74.
- Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006;55:221-7.
- Kastrup J, Johansen JS, Winkel P, et al.; CLARICOR Trial Group. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 2009;30:1066-72.
- Kocabas R. Effect of vitamin D on YKL-40: rat hypercholesterolemia model. Korean Circ J 2023;53:92-102.
- Can U, Uysal S, Ruveyda Ugur A, Toker A, Aslan U, Taha Hidayetoglu B. Can YKL-40 be an inflammatory biomarker in vitamin D deficiency? Int J Vitam Nutr Res 2019;89:309-13.
- Omidian M, Mahmoudi M, Javanbakht MH, et al. Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: a randomized, placebocontrolled, double-blind clinical trial. Diabetes Metab Syndr 2019;13:2873-7.
- Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019;380:33-44.